• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体重指数与非霍奇金淋巴瘤和霍奇金淋巴瘤风险的关系:前瞻性研究的荟萃分析。

Body mass index and risk of non-Hodgkin's and Hodgkin's lymphoma: a meta-analysis of prospective studies.

机构信息

Division of Nutritional Epidemiology, The National Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden.

出版信息

Eur J Cancer. 2011 Nov;47(16):2422-30. doi: 10.1016/j.ejca.2011.06.029. Epub 2011 Jul 4.

DOI:10.1016/j.ejca.2011.06.029
PMID:21733676
Abstract

We conducted a meta-analysis of prospective studies to summarise the epidemiologic evidence regarding the association of body mass index (BMI) with non-Hodgkin's lymphoma (NHL) and Hodgkin's lymphoma (HL) incidence and NHL mortality. Pertinent studies were identified by searching PubMed (1966-May 2011) and the reference lists of retrieved articles. For each study, we estimated a relative risk (RR) for a 5 kg/m(2) increase in BMI. A random-effects model was used to combine the RR estimates from individual studies. The summary RRs for a 5 kg/m(2) increase in BMI were 1.07 (95% confidence intervals (CI), 1.04-1.10) for NHL incidence (16 studies, n=17,291 cases) and 1.14 (95% CI, 1.04-1.26) for NHL mortality (five studies, n=3407 cases). BMI was significantly positively associated with risk of diffuse large B-cell lymphoma (RR, 1.13; 95% CI, 1.02-1.26), but not other NHL subtypes. The difference in risk estimates for subtypes was not statistically significant (P=0.10). There was evidence of a nonlinear association between BMI and HL (P for nonlinearity=0.01) (five studies, n=1557 cases). The summary RRs of HL were 0.97 (95% CI, 0.85-1.12) for overweight and 1.41 (95% CI, 1.14-1.75) for obesity. These results indicate that BMI is positively associated with risk of NHL and HL as well as with NHL mortality.

摘要

我们进行了一项荟萃分析,以总结前瞻性研究中有关体重指数(BMI)与非霍奇金淋巴瘤(NHL)和霍奇金淋巴瘤(HL)发病率以及 NHL 死亡率之间关联的流行病学证据。通过在 PubMed(1966 年-2011 年 5 月)上进行检索,并查阅已检索到的文章的参考文献,确定了相关研究。对于每项研究,我们估计了 BMI 每增加 5kg/m(2)时的相对风险(RR)。使用随机效应模型合并来自个体研究的 RR 估计值。BMI 每增加 5kg/m(2)时,NHL 发病率的汇总 RR 为 1.07(95%置信区间(CI),1.04-1.10)(16 项研究,n=17,291 例),NHL 死亡率的汇总 RR 为 1.14(95% CI,1.04-1.26)(五项研究,n=3407 例)。BMI 与弥漫性大 B 细胞淋巴瘤的风险呈显著正相关(RR,1.13;95% CI,1.02-1.26),但与其他 NHL 亚型无关。各亚型的风险估计值之间的差异无统计学意义(P=0.10)。BMI 与 HL 之间存在非线性关联(非线性检验 P=0.01)(五项研究,n=1557 例)。HL 的汇总 RR 为超重者 0.97(95% CI,0.85-1.12),肥胖者 1.41(95% CI,1.14-1.75)。这些结果表明,BMI 与 NHL 和 HL 的风险以及 NHL 死亡率呈正相关。

相似文献

1
Body mass index and risk of non-Hodgkin's and Hodgkin's lymphoma: a meta-analysis of prospective studies.体重指数与非霍奇金淋巴瘤和霍奇金淋巴瘤风险的关系:前瞻性研究的荟萃分析。
Eur J Cancer. 2011 Nov;47(16):2422-30. doi: 10.1016/j.ejca.2011.06.029. Epub 2011 Jul 4.
2
Obesity and risk of non-Hodgkin's lymphoma: a meta-analysis.肥胖与非霍奇金淋巴瘤风险:一项荟萃分析。
Int J Cancer. 2007 Oct 1;121(7):1564-70. doi: 10.1002/ijc.22762.
3
Anthropometrics, physical activity, related medical conditions, and the risk of non-hodgkin lymphoma.人体测量学、身体活动、相关医疗状况与非霍奇金淋巴瘤风险
Cancer Causes Control. 2005 Dec;16(10):1203-14. doi: 10.1007/s10552-005-0358-7.
4
Allergy-associated symptoms in relation to childhood non-Hodgkin's as contrasted to Hodgkin's lymphomas: a case-control study in Greece and meta-analysis.与儿童霍奇金淋巴瘤相比,与过敏相关的症状与非霍奇金淋巴瘤的关系:希腊的病例对照研究和荟萃分析。
Eur J Cancer. 2012 Aug;48(12):1860-6. doi: 10.1016/j.ejca.2011.12.010. Epub 2012 Jan 7.
5
Obesity and risk of non-Hodgkin lymphoma (United States).肥胖与非霍奇金淋巴瘤风险(美国)
Cancer Causes Control. 2007 Aug;18(6):677-85. doi: 10.1007/s10552-007-9013-9. Epub 2007 May 7.
6
Overweight and obesity at different times in life as risk factors for non-Hodgkin's lymphoma: the multiethnic cohort.不同生命阶段的超重和肥胖作为非霍奇金淋巴瘤的风险因素:多民族队列研究
Cancer Epidemiol Biomarkers Prev. 2008 Jan;17(1):196-203. doi: 10.1158/1055-9965.EPI-07-0716. Epub 2008 Jan 9.
7
Body mass index and risk of multiple myeloma: a meta-analysis of prospective studies.体重指数与多发性骨髓瘤风险:前瞻性研究的荟萃分析。
Eur J Cancer. 2011 Jul;47(11):1606-15. doi: 10.1016/j.ejca.2011.01.020. Epub 2011 Feb 25.
8
Body mass index, abnormal glucose metabolism, and mortality from hematopoietic cancer.体重指数、异常糖代谢与造血系统癌症死亡率
Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2348-54. doi: 10.1158/1055-9965.EPI-06-0007.
9
Body mass index and risk of malignant lymphoma in Scandinavian men and women.斯堪的纳维亚男性和女性的体重指数与恶性淋巴瘤风险
J Natl Cancer Inst. 2005 Feb 2;97(3):210-8. doi: 10.1093/jnci/dji012.
10
Anthropometric factors and non-Hodgkin's lymphoma risk: systematic review and meta-analysis of prospective studies.人体测量因素与非霍奇金淋巴瘤风险:前瞻性研究的系统评价和荟萃分析。
Crit Rev Oncol Hematol. 2018 Sep;129:113-123. doi: 10.1016/j.critrevonc.2018.05.018. Epub 2018 Jun 6.

引用本文的文献

1
Association of dynamic changes in metabolic syndrome components with clinical outcomes in diffuse large B-cell lymphoma.弥漫性大B细胞淋巴瘤中代谢综合征组分的动态变化与临床结局的关联
Front Oncol. 2025 Jun 16;15:1524498. doi: 10.3389/fonc.2025.1524498. eCollection 2025.
2
Obesity and overweight in R/R DLBCL patients is associated with a better response to treatment of R2-GDP-GOTEL trial. Potential role of NK CD8 + cells and vitamin D.复发/难治性弥漫性大B细胞淋巴瘤(R/R DLBCL)患者的肥胖和超重与R2-GDP-GOTEL试验的治疗反应较好相关。自然杀伤性CD8 +细胞和维生素D的潜在作用。
Cancer Metab. 2025 Mar 4;13(1):12. doi: 10.1186/s40170-025-00381-7.
3
Editorial: Obesity and cancer: the possible molecular links.
社论:肥胖与癌症:可能的分子联系
Front Cell Dev Biol. 2025 Feb 11;13:1542429. doi: 10.3389/fcell.2025.1542429. eCollection 2025.
4
Causal association of physical activity with lymphoma risk: a Mendelian randomization analysis.体力活动与淋巴瘤风险的因果关联:孟德尔随机化分析
Eur J Public Health. 2025 Feb 1;35(1):121-127. doi: 10.1093/eurpub/ckae172.
5
Body mass index and risk of over 100 cancer forms and subtypes in 4.1 million individuals in Sweden: the Obesity and Disease Development Sweden (ODDS) pooled cohort study.瑞典410万人的体重指数与100多种癌症类型及亚型的风险:瑞典肥胖与疾病发展(ODDS)汇总队列研究
Lancet Reg Health Eur. 2024 Aug 20;45:101034. doi: 10.1016/j.lanepe.2024.101034. eCollection 2024 Oct.
6
Etiology of non-Hodgkin lymphoma: A review from epidemiologic studies.非霍奇金淋巴瘤的病因:来自流行病学研究的综述
J Natl Cancer Cent. 2022 Aug 17;2(4):226-234. doi: 10.1016/j.jncc.2022.08.003. eCollection 2022 Dec.
7
The causal effect of adipose tissue on Hodgkin's lymphoma: two-sample Mendelian randomization study and validation.脂肪组织对霍奇金淋巴瘤的因果关系:两样本孟德尔随机化研究及验证。
Front Immunol. 2024 May 30;15:1400756. doi: 10.3389/fimmu.2024.1400756. eCollection 2024.
8
The Obesity Controversy: Does It Impact Treatment Response in Diffuse Large B-Cell Lymphoma?肥胖争议:它是否会影响弥漫性大B细胞淋巴瘤的治疗反应?
Int J Hematol Oncol Stem Cell Res. 2023 Apr 1;17(2):75-80. doi: 10.18502/ijhoscr.v17i2.12643.
9
Impact of Quantitative Computed Tomography-Based Analysis of Abdominal Adipose Tissue in Patients with Lymphoma.基于定量计算机断层扫描的腹部脂肪组织分析对淋巴瘤患者的影响。
Hematol Rep. 2023 Aug 4;15(3):474-482. doi: 10.3390/hematolrep15030049.
10
Association of Obesity and Type 2 Diabetes with Non-Hodgkin Lymphoma: The Multiethnic Cohort.肥胖和 2 型糖尿病与非霍奇金淋巴瘤的关联:多民族队列研究。
Cancer Epidemiol Biomarkers Prev. 2023 Oct 2;32(10):1348-1355. doi: 10.1158/1055-9965.EPI-23-0565.